Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Ho

Showing results (221-230 of 321) with videos related to

Pageof 33
Sort By:
Leukemia|July 29, 2000
CD19+ and CD20+ B cells from the peripheral blood of patients with multiple myeloma are not infected with human herpesvirus 8T Bösing, F Bellos, F W Cremer, et al.
Blood|January 1, 1990
Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphomaA D Ho, R Haas, G Wulf, et al.
Bone Marrow Transplantation|January 10, 2006
Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trialC Harter, B Schulze, H Goldschmidt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatmentS Glück, A A Ross, T J Layton, et al.
BMC Cancer|April 13, 2016
Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphomaK Lisenko, F McClanahan, T Schöning, et al.
Leukemia|September 14, 1999
Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemiaS Stilgenbauer, L Bullinger, A Benner, et al.
British Journal of Haematology|June 3, 1999
Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patientsS Fruehauf, K Schmitt, M R Veldwijk, et al.
Leukemia|October 1, 1991
Assessment of bone marrow infiltration by magnetic resonance imaging in patients with hairy cell leukemia treated with pentostatin or alpha-interferonM Bentz, H Döhner, F Gückel, et al.
Leukemia|October 1, 1989
Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapyA D Ho, M Grossmann, W Knauf, et al.
Annals of Hematology|August 14, 2015
The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphomaM Madle, I Krämer, N Lehners, et al.
Pageof 33

Showing results (221-230 of 321) with videos related to

Sort By:
Pageof 33
Leukemia|July 29, 2000
CD19+ and CD20+ B cells from the peripheral blood of patients with multiple myeloma are not infected with human herpesvirus 8T Bösing, F Bellos, F W Cremer, et al.
Blood|January 1, 1990
Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphomaA D Ho, R Haas, G Wulf, et al.
Bone Marrow Transplantation|January 10, 2006
Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trialC Harter, B Schulze, H Goldschmidt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatmentS Glück, A A Ross, T J Layton, et al.
BMC Cancer|April 13, 2016
Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphomaK Lisenko, F McClanahan, T Schöning, et al.
Leukemia|September 14, 1999
Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemiaS Stilgenbauer, L Bullinger, A Benner, et al.
British Journal of Haematology|June 3, 1999
Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patientsS Fruehauf, K Schmitt, M R Veldwijk, et al.
Leukemia|October 1, 1991
Assessment of bone marrow infiltration by magnetic resonance imaging in patients with hairy cell leukemia treated with pentostatin or alpha-interferonM Bentz, H Döhner, F Gückel, et al.
Leukemia|October 1, 1989
Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapyA D Ho, M Grossmann, W Knauf, et al.
Annals of Hematology|August 14, 2015
The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphomaM Madle, I Krämer, N Lehners, et al.
Pageof 33